Thursday, July 9, 2026

biotech · Glanzmann Thrombasthenia · Von Willebrand Disease (VWD) · COAG

Hemab Therapeutics Holdings

Hemab Therapeutics Holdings trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

frederiksberg, DK HQ
2020 Founded
90 Employees
Public company Type
COAG · NYSE Ticker
Company details
Status
Public
HQ
frederiksberg, DK
Founded
2020
Employees
90
Programs
4
Drugs
0
Patents
0
Intelligence · Clinical Trials

Hemab Therapeutics Holdings clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Hemab Therapeutics Holdings programs — each row shows trial ID, program name, phase, status, and indication.

Hemab Therapeutics Holdings trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Hemab Therapeutics Holdings.

  1. HMB-001 — Phase 2

    Clinical update
  2. HMB-001 — Phase 2

    Clinical update
  3. HMB-002 (Part A) — Phase 2

    Clinical update
  4. Sutacimig — Phase 2

    Clinical update

Trial registry

4 studies